• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG VATION XF TIBIA CEMENTED T2 RM; KNEE ENDOPROSTHESES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG VATION XF TIBIA CEMENTED T2 RM; KNEE ENDOPROSTHESES Back to Search Results
Model Number NO157Z
Device Problem Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problem Failure of Implant (1924)
Event Date 08/25/2022
Event Type  Injury  
Manufacturer Narrative
Manufacturing site evaluation: investigation on-going.Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that there was an issue with no157z - as univation xf tibia cemented t2 rm.According to the complaint description, the patient presented to hospital on (b)(6) 2022 due to persistent right knee pain.An arthroscopy was performed on (b)(6) 2022.Pathological report showed abrasion of the knee prosthesis.A revision surgery was necessary.Additional information was not provided.The adverse event is filed under aag reference (b)(4).Associated medwatch-reports: (9610612-2022-00398 - no181z) - (b)(4).Involved components: nl483 - univation f meniscal comp.T2 rm/lm 9mm - lot 52121429.
 
Manufacturer Narrative
Investigation results: visual investigation: the available explants are in an undamaged condition and show no serious abnormalities or deviations.In the delivered condition the femoral component shows a firmly fixed cement mantle fragment on the intended area/coated surface.These bone cement residues show bone anchorage (cement interlock into the bone trabeculae).The provided tibial component shows almost no bone cement residues on the intended area/ coated surface.The discolorations on the surface of the gliding surface of the femoral component is due to oxidation.Such changes in color have no effect on the function or properties of the coating.The gliding surface of the meniscal component shows visible scratches and imprints.These imprints are probably resulting from third body wear (bone chips and/or bone cement residues).Furthermore there are massive wear in the border area of the gliding surface.Batch history review: the device quality and manufacturing history records have been checked for the available lot number and were found to be according to our specifications valid at the time of production.Review of the complaint history revealed that no similar complaints have been filed against products from this batch number.The review of risk assessment revealed that the overall risk level (severity 4(5) x probability 4(5) of occurrence) according to din en iso 14971 is still acceptable.Explanation and rationale: on the basis of the current information, a clear conclusion cannot be drawn.The device history records have been checked and no abnormalities could be observed.There are no hints for a material/device problem.There are several and often complex root causes for an implant loosening.Possibly due to septic conditions or, for example, to incorrect loading, too early or too high loading, which may also have occurred long before the onset of loosening, suboptimal positioning (due to the patient), inappropriate choice of implant, inappropriate surgical procedure or inappropriate cementing technique, and many others.Conclusion and measures / preventive measures: based upon the investigation results a clear root cause conclusion cannot be drawn.There is no indication for a material-,manufacturing- or design-related failure.Based upon the investigations results a capa is not necessary.
 
Event Description
The adverse event is filed under aag reference (b)(4) ((b)(4)).Associated medwatch-reports: (9610612-2022-00398 - no181z) - (b)(4).Involved components: nl483 - univation f meniscal comp.T2 rm/lm 9mm - lot 52121429.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VATION XF TIBIA CEMENTED T2 RM
Type of Device
KNEE ENDOPROSTHESES
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
Manufacturer (Section G)
AESCULAP AG
po box 40
tuttlingen, 78501
GM   78501
Manufacturer Contact
christian von der grün
po box 40
tuttlingen, 78501
GM   78501
MDR Report Key16184186
MDR Text Key307482898
Report Number9610612-2022-00399
Device Sequence Number1
Product Code HRY
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K131167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNO157Z
Device Catalogue NumberNO157Z
Device Lot Number52198595
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/05/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/21/2005
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NL483 - LOT 52121429.; NL483 - LOT 52121429.
Patient Outcome(s) Required Intervention;
Patient Age56 YR
Patient SexFemale
-
-